logo
  

Dr. Reddy's To Launch Generic Version Of Librax - Quick Facts

Dr. Reddy's Laboratories Ltd. (RDY) announced the U.S. launch of Chlordiazepoxide Hydrochloride and Clidinium Bromide Capsules USP, a therapeutic equivalent generic version of Librax. Dr. Reddy's Chlordiazepoxide Hydrochloride and Clidinium Bromide Capsules, USP are available in one strength of 5 mg/2.5 mg capsules in bottle count sizes of 100.

The company noted that Librax brand and generic market had U.S. sales of approximately
$105.9 million MAT for the most recent twelve months ending in July 2021.

Dr. Reddy's is an an integrated pharmaceutical company offering a portfolio of products
and services including APIs, custom pharmaceutical services, generics, biosimilars and differentiated formulations.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Stocks staged a significant recovery attempt after pulling back sharply in early trading on Wednesday but still ended the day modestly lower. The major averages gave back ground after moving sharply higher over the two previous sessions. Three scientists have shared the Nobel Prize for Chemistry for their work that led to the development of linking molecules together, known as click chemistry, and bioorthogonal chemistry. Morten Meldal and K. Barry Sharpless have laid the foundation for a functional form of chemistry - click chemistry - in which molecular building blocks snap together quickly and efficiently. Carolyn R. Bertozzi The Institute for Supply Management released a report on Wednesday showing a modest slowdown in the pace of growth in U.S. service sector activity in the month of September. The ISM said its services PMI edged down to 56.7 in September from 56.9 in August, although a reading above 50 still indicates growth in the sector.
Follow RTT